Physician profile
Susan K Steele
NPI 1760453591
$769.63
in general payments reported to CMS, 2019-2025
12 companies · $15.00 in 2025
The $15.00 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $59.43 · 2021: $321 · 2022: $43.08 · 2023: $23.06 · 2025: $15.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $267.72 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.47 | 2019-2020 | |
| Amarin Pharma, INC. | $101.61 | 2019 | |
| Novo Nordisk INC | $84.84 | 2019 | |
| Horizon Therapeutics Plc | $41.23 | 2021-2022 | |
| Abbvie INC. | $37.02 | 2022-2023 | Ubrelvy |
| Amgen INC. | $20.97 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $19.94 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.20 | 2020 | |
| Revance Therapeutics, INC. | $15.00 | 2025 | Daxxify |
| Glaxosmithkline, LLC. | $13.21 | 2020 | |
| Siemens Medical Solutions USA, INC. | $11.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.